POCKiT diagnostics is developing a fully automated blood test for stroke diagnosis, targeting a market of 20 million people. Their innovative product comprises a reader system priced at around £1000 and disposable cartridges at £100 each. The B2B model primarily targets public and private healthcare providers and health insurance companies such as NHS. Clinicians and paramedics use the product by inserting blood samples into the cartridge, providing diagnostic results in just 20 minutes.
The market potential is significant, with approximately 20 million people requiring stroke diagnosis annually in the UK, and this number expected to rise by 44% in the next 15 years due to an ageing population.
Founded in 2017, POCKiT diagnostics represents an innovative approach to addressing the growing need for efficient and accessible stroke diagnosis, offering a promising investment opportunity in the healthcare technology sector for investors.
